Samsung Biologics

companyCH

Launch your RWA with Curio

Tokenize your real-world asset with Curio

[1] SIGNALS · 2

M&A / successionCH·1mo ago✦ enriched

Samsung Biologics to launch takeover bid for PolyPeptide in September | MWC Sandbox/Syndication

Samsung Biologics plans a September takeover bid for PolyPeptide Group worth 1.46 billion Swiss francs ($1.80 billion), with the objective to delist PolyPeptide from the Swiss market.

WATCH· 54intent / 100

Samsung Biologics|d2233.cms.socastsrm.com ↗

M&A / successionCH·2mo ago

Samsung Biologics buys PolyPeptide for $1.8bn

Samsung Biologics announced an all-cash tender offer to acquire PolyPeptide Group AG for about CHF 1.46 billion ($1.8 billion), signaling a bold, large-scale expansion into peptide CDMO capabilities.

WATCH· 53intent / 100

Samsung Biologics|bioxconomy.com ↗

followGet a digest when Samsung Biologics fires.